Skip to main content

Table 5 Biosafety assessment of H7N9 CVVs

From: Development of high-growth influenza H7N9 prepandemic candidate vaccine viruses in suspension MDCK cells

CVVsCELD50a
Wild-type H7N9 (A/Taiwan/1/2017)10–1.17 TCID50
NHRI-RG3> 106.65 TCID50
NHRI-RG4> 107.04 TCID50
NHRI-RG5> 107.65 TCID50
NHRI-RG6> 106.65 TCID50
  1. Note: aCELD50: median chicken embryo lethal dose; expressed as median tissue culture infectious dose (TCID50)